Benitec Biopharma Inc (BNTC) Directors and Executive Officers

Officers & Directors

Benitec Biopharma Inc. Executives and Directors:

- Dr. Jerel Banks
Chief Executive Officer, Director (principal executive officer)

- Megan Boston
Executive Director, Director (principal accounting and financial officer)

- J. Kevin Buchi
Director

- Edward Smith
Director

- Kishan (Kishen) Mehta
Director

- Peter Francis
Director

Auditor:
Baker Tilly US, LLP - Served as the Company s auditor since [specific date not provided].,

Benitec Biopharma Inc currently has 24 employees.

News about Benitec Biopharma Inc Key Personnel

Benitec Biopharma Inc Raises $40 Million in Oversubscribed Private Placement Financing, Fueling Groundbreaking Gene Therapy Advancements

Rejuvenated Investor Confidence Fuels Benitec Biopharma s Successful $40 Million Private Placement Financing
HAYWARD, Calif., April 18, 2024 – Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company specializing in gene therapy, proudly announced today the successful completion of an oversubscribed private investment in public equity (PIPE) financing, securing an impressive $40.0 million. This financing round exemplifies the increased investor confidence in Benitec s mission to develop revolutionary genetic medicines using their groundbreaking Silence and Replace DNA-directed RNA interference (ddRNAi) platform.
Leading this oversubscribed financing was Suvretta Capital Manage...